PD-1 (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "PD-1" in Persian language version.

Last modified: 01:08:07, 28 September 2026 (UTC)

Ref.Un. Ref.Website

Global rank Persian rank

1716nih.gov

5^th place

3^rd place

1310doi.org

2^nd place

62ensembl.org

630^th place

387^th place

41elsevier.com

365^th place

416^th place

21web.archive.org

1^st place

11wsj.com

94^th place

104^th place

11archive.org

6^th place

4^th place

11nature.com

207^th place

262^nd place

archive.org (Global: 6^th place; Persian: 4^th place)

Weber J (October 2010). "Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade". Seminars in Oncology. 37 (5): 430–9. doi:10.1053/j.seminoncol.2010.09.005. PMID 21074057.

doi.org (Global: 2^nd place; Persian: 2^nd place)

Francisco LM, Sage PT, Sharpe AH (July 2010). "The PD-1 pathway in tolerance and autoimmunity". Immunological Reviews. 236: 219–42. doi:10.1111/j.1600-065X.2010.00923.x. PMC 2919275. PMID 20636820.
Fife BT, Pauken KE (January 2011). "The role of the PD-1 pathway in autoimmunity and peripheral tolerance". Annals of the New York Academy of Sciences. 1217: 45–59. doi:10.1111/j.1749-6632.2010.05919.x. PMID 21276005.
Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A. "De-novo and acquired resistance to immune checkpoint targeting". The Lancet Oncology (in English). 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1.
Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T (October 1994). "Structure and chromosomal localization of the human PD-1 gene (PDCD1)". Genomics. 23 (3): 704–6. doi:10.1006/geno.1994.1562. PMID 7851902.
Wang X, Teng F, Kong L, Yu J (August 2016). "PD-L1 expression in human cancers and its association with clinical outcomes". OncoTargets and Therapy. 9: 5023–39. doi:10.2147/OTT.S105862. PMC 4990391. PMID 27574444.{{cite journal}}: نگهداری یادکرد:doi رایگان بی‌نشان (رده)
Gandini S, Massi D, Mandalà M (April 2016). "PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis". Critical Reviews in Oncology/Hematology. 100: 88–98. doi:10.1016/j.critrevonc.2016.02.001. PMID 26895815.
Weber J (October 2010). "Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade". Seminars in Oncology. 37 (5): 430–9. doi:10.1053/j.seminoncol.2010.09.005. PMID 21074057.
Porichis F, Kaufmann DE (March 2012). "Role of PD-1 in HIV pathogenesis and as target for therapy". Current HIV/AIDS Reports. 9 (1): 81–90. doi:10.1007/s11904-011-0106-4. PMC 3731769. PMID 22198819.
Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC (January 2016). "TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection". PLoS Pathogens. 12 (1): e1005349. doi:10.1371/journal.ppat.1005349. PMC 4704737. PMID 26741490.{{cite journal}}: نگهداری یادکرد:doi رایگان بی‌نشان (رده) نگهداری یادکرد:شماره مقاله به‌جای شماره صفحه (رده)
Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, Kertser A, David E, Amit I, Schwartz M (February 2016). "PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease". Nature Medicine (in English). 22 (2): 135–7. doi:10.1038/nm.4022. PMID 26779813.

elsevier.com (Global: 365^th place; Persian: 416^th place)

linkinghub.elsevier.com

Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A. "De-novo and acquired resistance to immune checkpoint targeting". The Lancet Oncology (in English). 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1.

ensembl.org (Global: 630^th place; Persian: 387^th place)

may2017.archive.ensembl.org

ENSG00000276977 GRCh38: Ensembl release 89: ENSG00000188389، ENSG00000276977 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000026285 – Ensembl, May 2017

nature.com (Global: 207^th place; Persian: 262^nd place)

Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, Kertser A, David E, Amit I, Schwartz M (February 2016). "PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease". Nature Medicine (in English). 22 (2): 135–7. doi:10.1038/nm.4022. PMID 26779813.

nih.gov (Global: 5^th place; Persian: 3^rd place)

pubmed.ncbi.nlm.nih.gov

Francisco LM, Sage PT, Sharpe AH (July 2010). "The PD-1 pathway in tolerance and autoimmunity". Immunological Reviews. 236: 219–42. doi:10.1111/j.1600-065X.2010.00923.x. PMC 2919275. PMID 20636820.
Fife BT, Pauken KE (January 2011). "The role of the PD-1 pathway in autoimmunity and peripheral tolerance". Annals of the New York Academy of Sciences. 1217: 45–59. doi:10.1111/j.1749-6632.2010.05919.x. PMID 21276005.
Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T (October 1994). "Structure and chromosomal localization of the human PD-1 gene (PDCD1)". Genomics. 23 (3): 704–6. doi:10.1006/geno.1994.1562. PMID 7851902.
Wang X, Teng F, Kong L, Yu J (August 2016). "PD-L1 expression in human cancers and its association with clinical outcomes". OncoTargets and Therapy. 9: 5023–39. doi:10.2147/OTT.S105862. PMC 4990391. PMID 27574444.{{cite journal}}: نگهداری یادکرد:doi رایگان بی‌نشان (رده)
Gandini S, Massi D, Mandalà M (April 2016). "PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis". Critical Reviews in Oncology/Hematology. 100: 88–98. doi:10.1016/j.critrevonc.2016.02.001. PMID 26895815.
Weber J (October 2010). "Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade". Seminars in Oncology. 37 (5): 430–9. doi:10.1053/j.seminoncol.2010.09.005. PMID 21074057.
Porichis F, Kaufmann DE (March 2012). "Role of PD-1 in HIV pathogenesis and as target for therapy". Current HIV/AIDS Reports. 9 (1): 81–90. doi:10.1007/s11904-011-0106-4. PMC 3731769. PMID 22198819.
Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC (January 2016). "TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection". PLoS Pathogens. 12 (1): e1005349. doi:10.1371/journal.ppat.1005349. PMC 4704737. PMID 26741490.{{cite journal}}: نگهداری یادکرد:doi رایگان بی‌نشان (رده) نگهداری یادکرد:شماره مقاله به‌جای شماره صفحه (رده)
Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, Kertser A, David E, Amit I, Schwartz M (February 2016). "PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease". Nature Medicine (in English). 22 (2): 135–7. doi:10.1038/nm.4022. PMID 26779813.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Francisco LM, Sage PT, Sharpe AH (July 2010). "The PD-1 pathway in tolerance and autoimmunity". Immunological Reviews. 236: 219–42. doi:10.1111/j.1600-065X.2010.00923.x. PMC 2919275. PMID 20636820.
"Entrez Gene: PDCD1 programmed cell death 1". Archived from the original on 16 اوت 2018.
Wang X, Teng F, Kong L, Yu J (August 2016). "PD-L1 expression in human cancers and its association with clinical outcomes". OncoTargets and Therapy. 9: 5023–39. doi:10.2147/OTT.S105862. PMC 4990391. PMID 27574444.{{cite journal}}: نگهداری یادکرد:doi رایگان بی‌نشان (رده)
Porichis F, Kaufmann DE (March 2012). "Role of PD-1 in HIV pathogenesis and as target for therapy". Current HIV/AIDS Reports. 9 (1): 81–90. doi:10.1007/s11904-011-0106-4. PMC 3731769. PMID 22198819.
Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC (January 2016). "TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection". PLoS Pathogens. 12 (1): e1005349. doi:10.1371/journal.ppat.1005349. PMC 4704737. PMID 26741490.{{cite journal}}: نگهداری یادکرد:doi رایگان بی‌نشان (رده) نگهداری یادکرد:شماره مقاله به‌جای شماره صفحه (رده)

web.archive.org (Global: 1^st place; Persian: 1^st place)

"Entrez Gene: PDCD1 programmed cell death 1". Archived from the original on 16 اوت 2018.

wsj.com (Global: 94^th place; Persian: 104^th place)

online.wsj.com

Loftus, Peter (16 Nov 2014). "New Bristol-Myers Drug Helped Skin-Cancer Patients in Trial Live Longer". Retrieved 24 Nov 2014.

PD-1 (Persian Wikipedia)

archive.org (Global: 6th place; Persian: 4th place)

doi.org (Global: 2nd place; Persian: 2nd place)

elsevier.com (Global: 365th place; Persian: 416th place)